Hoth Therapeutics is a development stage biopharmaceutical company focused on targeted therapeutics for patients suffering from indications such as atopic dermatitis. The Company also develops the BioLexa Platform, a product candidate intended to prevent the symptom-triggering flare-ups before they occur.